Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: J Clin Psychopharmacol. 2019 Mar-Apr;39(2):108–116. doi: 10.1097/JCP.0000000000001015

Figure 2.

Figure 2.

Comparison of Continuous Abstinence Rates

2a. Observed Rates of Continuous Abstinence for Study Weeks 9-12

2b. Comparison of Odds of Continuous Abstinence for Weeks 9-12 by Treatment Assignment and Diagnostic Group*

* From GLIMMIX model that included terms for treatment, psychiatric diagnostic group, sex, FTND total score, prior alcohol or substance use disorder, and region